Enhanced NF-?B signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis. (2021)

First Author: Andres-Ejarque R
Attributed to:  MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-25066-9

PubMed Identifier: 34362923

Publication URI: http://europepmc.org/abstract/MED/34362923

Type: Journal Article/Review

Volume: 12

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723